首页> 外文OA文献 >Prospective Study of a Pirarubicin, Intermediate-Dose Cytarabine, and Etoposide Regimen in Children With Down Syndrome and Acute Myeloid Leukemia: The Japanese Childhood AML Cooperative Study Group

【2h】

Prospective Study of a Pirarubicin, Intermediate-Dose Cytarabine, and Etoposide Regimen in Children With Down Syndrome and Acute Myeloid Leukemia: The Japanese Childhood AML Cooperative Study Group

机译：患有唐氏综合症和急性髓性白血病的儿童中吡柔比星，中剂量阿糖胞苷和依托泊苷方案的前瞻性研究：日本儿童amL合作研究组

页面导航

著录项
相似文献
相关主题

著录项

作者
Kazuko Kudo; Seiji Kojima; Ken Tabuchi; Hiromasa Yabe; Akio Tawa; Masue Imaizumi; Ryoji Hanada; Kazuko Hamamoto; Ryoji Kobayashi; Akira Morimoto; Hideki Nakayama; Masahiro Tsuchida; Keizo Horibe; Hisato Kigasawa; Ichiro Tsukimoto;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group. [J] . Kudo K, Kojima S, Tabuchi K, Journal of Clinical Oncology . 2007,第34期

机译：唐拉综合征和急性髓性白血病儿童中吡柔比星，中等剂量阿糖胞苷和依托泊苷方案的前瞻性研究：日本儿童AML合作研究小组。
2. Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative study [J] . Masue Imaizumi, Akio Tawa, Ryoji Hanada, British Journal of Haematology . 2011,第1期

机译：全反式维甲酸和蒽环类药物联合阿糖胞苷治疗急性早幼粒细胞白血病儿童的前瞻性研究：日本儿童急性髓样白血病合作研究
3. Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: The Japanese childhood acute myeloid leukaemia cooperative study [J] . Imaizumi M., Tawa A., Hanada R., British Journal of Haematology . 2010,第1期

机译：全反式维甲酸和蒽环类药物联合阿糖胞苷治疗儿童急性早幼粒细胞白血病的前瞻性研究：日本儿童急性髓样白血病合作研究
4. Clinical Trials for Childhood Acute Myeloid Leukemia at St. Jude Children's Research Hospital, 1980 through 2005 [C] . . 2006

机译：1980年至2005年在圣裘德儿童研究医院进行的儿童急性髓性白血病临床试验
5. Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study [D] . Harada Yasuhiko, 原田靖彦 2019

机译：根据2017年日本成人白血病研究组（JALSG）AML201研究治疗的成人急性髓性白血病患者的遗传学预测，根据2017 ELN风险分层进行预后分析
6. A Phase 2 Study of Bortezomib Combined with Either Idarubicin/Cytarabine or Cytarabine/Etoposide in Children with Relapsed Refractory or Secondary Acute Myeloid Leukemia: A Report from the Childrens Oncology Group [O] . Terzah M. Horton, John P. Perentesis, Alan S. Gamis, -1

机译：硼替佐米联合伊达比星/阿糖胞苷或阿糖胞苷/依托泊苷治疗复发性难治性或继发性急性髓性白血病儿童的第二阶段研究：儿童肿瘤学组的报告
7. N822 mutation of KIT gene was frequent in pediatric acute myeloid leukemia patients with t(8;21) in Japan: a study of the Japanese childhood AML cooperative study group [O] . A Shimada, T Taki, C Kubota, 2007

机译：KIT基因的N822突变在日本T（8; 21）的小儿急性髓性白血病患者中经常出现：日本儿童AML合作研究组的研究

Prospective Study of a Pirarubicin, Intermediate-Dose Cytarabine, and Etoposide Regimen in Children With Down Syndrome and Acute Myeloid Leukemia: The Japanese Childhood AML Cooperative Study Group

著录项

相似文献

相关主题

期刊订阅